These trials provide important insight into the optimal dosing of ARBs by assessing the relationship of dose of drug and risk reduction for both heart and kidney disease. All of the major trials ...

Our intervention reduced the proportion of patients with prescriptions exceeding the recommended maximum daily dose, with a trend in reducing the proportion of patients with at least one ...

7 No relevant data are available for high-dose ARBs. In any event, most patients with CKD will need treatment with both classes of medications given the superior antiproteinuric effect of dual ...